To establish postmarket reporting requirements for pharmaceuticals, and for other purposes.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To establish postmarket reporting requirements for pharmaceuticals, and for other purposes., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Defense, Trade.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H5A3476C1C6DA451BA2711DECAE17ABAE: 1. Short title This Act may be cited as the Further Strengthening America’s Supply Chain and National Security Act.
- Section HAC234FD0719A4B63A1132269026F1046: 2. Modification of rules of origin for pharmaceutical products Section 308(4)(B) of the Trade Agreements Act of 1979 (19 U.S.C. 2518(4)(B)) is amended— in...
- Section H05CCF3400BEA4D108076E8D76965E148: 3. Postmarket reporting requirements for pharmaceuticals The Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, shall...
- Section H3CA9DBE1C61E472F949960305D89068D: 4. Additional risk factors for consideration during inspections of drug and device establishments Section 510(h)(4) of the Federal Food, Drug, and Cosmetic Act...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To establish postmarket reporting requirements for pharmaceuticals, and for other purposes., changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Defense, Trade
Primary Purpose
This bill, To establish postmarket reporting requirements for pharmaceuticals, and for other purposes., changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Legislative Progress
IntroducedMr. Waltz introduced the following bill; which was referred to …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_commission"
- → The commission identified in the operative section
- "secretary_of_defense"
- → Secretary of Defense
- "secretary_of_health_and_human_services"
- → Secretary of Health and Human Services
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology